SurModics bolsters IVD business with CodeLink microarray tech
This article was originally published in Clinica
Executive Summary
In a bid to strengthen its in vitro diagnostics offering, surface modification and drug delivery firm SurModics has purchased the CodeLink activated slide microarray business from GE Healthcare.